Showing results (1-10 of 19) with videos related to
Sort By:
Pageof 2
Immunology Letters|December 9, 2004
Immune-based therapies for prostate cancerDouglas G McNeel, Miroslav MalkovskyImmunology Letters|November 14, 2017
Immunological considerations underlying heat shock protein-mediated cancer vaccine strategiesMatthew Kelly, Douglas McNeel, Paul Fisch, et al.Cancer Immunology, Immunotherapy : CII|January 25, 2008
CD40 ligation in vivo can induce T cell independent antitumor effects even against immunogenic tumorsAlexander L Rakhmilevich, Ilia N Buhtoiarov, Miroslav Malkovsky, et al.Plos One|May 29, 2019
Molecular detection of human T-lymphotropic virus type 1 infection among oncology patients in Germany: A retrospective viewMatias Ruggieri, Carolina Berini, Nicolas Ducasa, et al.Journal of Immunological Methods|April 26, 2016
Improved analysis of TCRγδ variable region expression in humansPetros Christopoulos, Daniela Bukatz, Sylvia Kock, et al.Immunology Letters|August 24, 2005
Vgamma9Vdelta2 T cell-mediated non-cytolytic antiviral mechanisms and their potential for cell-based therapyFabrizio Poccia, Chiara Agrati, Federico Martini, et al.Microbes and Infection|March 22, 2005
Antiviral reactivities of gammadelta T cellsFabrizio Poccia, Chiara Agrati, Federico Martini, et al.Journal of Scleroderma and Related Disorders|April 6, 2022
Therapeutic plasma exchange for the treatment of systemic sclerosis: A comprehensive review and analysisEdward S Harris, Herbert J Meiselman, Patrick M Moriarty, et al.Journal of Immunology (Baltimore, Md. : 1950)|August 28, 2009
Cutting edge: TGF-beta1 and IL-15 Induce FOXP3+ gammadelta regulatory T cells in the presence of antigen stimulationRita Casetti, Chiara Agrati, Marianne Wallace, et al.Journal of Immunology (Baltimore, Md. : 1950)|July 22, 2005
Drug-induced expansion and differentiation of V gamma 9V delta 2 T cells in vivo: the role of exogenous IL-2Rita Casetti, Gemma Perretta, Alessandra Taglioni, et al.Pageof 2